BACKGROUND:: Rosuvastatin is a new statin indicated to reduce elevated levels of total
cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides and to increase
levels of high-density lipoprotein cholesterol (HDL-C) in patients with primary
hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia.
OBJECTIVE:: The purpose of this article was to review the pharmacology, clinical efficacy,
and tolerability of rosuvastatin as monotherapy and combination therapy for patients with …